Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis

Background:- Renal failure may lead to increased inflammatory responses through a number of mechanisms which include decreased clearance of proinflammatory cytokines, decreased levels of antioxidant , that lead to increase of oxidative stress , nephrons are destroyed and kidney function is reduced...

Full description

Bibliographic Details
Main Author: Salma Abdul Rudha Abbas
Format: Article
Language:English
Published: College of medicine/ University of Diyala 2019-11-01
Series:Diyala Journal of Medicine
Subjects:
Online Access:http://djm.uodiyala.edu.iq/index.php/djm/article/view/360
_version_ 1797454760676163584
author Salma Abdul Rudha Abbas
author_facet Salma Abdul Rudha Abbas
author_sort Salma Abdul Rudha Abbas
collection DOAJ
description Background:- Renal failure may lead to increased inflammatory responses through a number of mechanisms which include decreased clearance of proinflammatory cytokines, decreased levels of antioxidant , that lead to increase of oxidative stress , nephrons are destroyed and kidney function is reduced . Objective:- The aims of this study were to determination the differences in the levels of interleukin-35 (IL-35) in patients with chronic renal failure (CRF) on hemodialysis and compare with control group. Method:- Sixty male individuals (age 40-60) were enrolled in this study which were divided into two groups as follows: Group (C) consisted of 30 healthy individuals as a control subject, (30) patients with (CRF) which were collected of their serum pre and post hemodialysis and control. IL-35, hs-CRP, TAC, MDA, MDA/TAC, urea, creatinine, uric acid, albumin levels were evaluated. Results:- The results in this study revealed that mean of serum IL-35 levels were significantly increased differences in patients with (CRF) pre and post hemodialysis compared with control group and a significant positive correlation between IL-35 and (MDA, MDA/TAC) in patients with pre and post dialysis patients with CRF. Conclusion:- Our findings suggest that a high IL-35 level most possibly reflect that the patients with (CRF) are associated and the positive correlation with oxidant-antioxidant status. Therefore, we suggest that possible antioxidant strategies that can be used therapeutically for better management of (CRF).
first_indexed 2024-03-09T15:42:46Z
format Article
id doaj.art-54dfee49d44145bc9c81ba84c90bc7e2
institution Directory Open Access Journal
issn 2219-9764
2617-8982
language English
last_indexed 2024-03-09T15:42:46Z
publishDate 2019-11-01
publisher College of medicine/ University of Diyala
record_format Article
series Diyala Journal of Medicine
spelling doaj.art-54dfee49d44145bc9c81ba84c90bc7e22023-11-24T23:23:52ZengCollege of medicine/ University of DiyalaDiyala Journal of Medicine2219-97642617-89822019-11-0161Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on HemodialysisSalma Abdul Rudha Abbas Background:- Renal failure may lead to increased inflammatory responses through a number of mechanisms which include decreased clearance of proinflammatory cytokines, decreased levels of antioxidant , that lead to increase of oxidative stress , nephrons are destroyed and kidney function is reduced . Objective:- The aims of this study were to determination the differences in the levels of interleukin-35 (IL-35) in patients with chronic renal failure (CRF) on hemodialysis and compare with control group. Method:- Sixty male individuals (age 40-60) were enrolled in this study which were divided into two groups as follows: Group (C) consisted of 30 healthy individuals as a control subject, (30) patients with (CRF) which were collected of their serum pre and post hemodialysis and control. IL-35, hs-CRP, TAC, MDA, MDA/TAC, urea, creatinine, uric acid, albumin levels were evaluated. Results:- The results in this study revealed that mean of serum IL-35 levels were significantly increased differences in patients with (CRF) pre and post hemodialysis compared with control group and a significant positive correlation between IL-35 and (MDA, MDA/TAC) in patients with pre and post dialysis patients with CRF. Conclusion:- Our findings suggest that a high IL-35 level most possibly reflect that the patients with (CRF) are associated and the positive correlation with oxidant-antioxidant status. Therefore, we suggest that possible antioxidant strategies that can be used therapeutically for better management of (CRF). http://djm.uodiyala.edu.iq/index.php/djm/article/view/360IL-35, antioxidant, chronic renal failure
spellingShingle Salma Abdul Rudha Abbas
Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
Diyala Journal of Medicine
IL-35, antioxidant, chronic renal failure
title Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
title_full Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
title_fullStr Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
title_full_unstemmed Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
title_short Determination of Interleukin-35 in Sera of Male Patients with Chronic Renal Failure on Hemodialysis
title_sort determination of interleukin 35 in sera of male patients with chronic renal failure on hemodialysis
topic IL-35, antioxidant, chronic renal failure
url http://djm.uodiyala.edu.iq/index.php/djm/article/view/360
work_keys_str_mv AT salmaabdulrudhaabbas determinationofinterleukin35inseraofmalepatientswithchronicrenalfailureonhemodialysis